(Q46713995)

24 December 2017

title

An experimental and molecular-modeling study of the binding of linked sulfated tetracyclitols to FGF-1 and FGF-2. (English)

1 reference

24 December 2017

author name string

Siska Cochran

series ordinal

1

1 reference

24 December 2017

Cai Ping Li

series ordinal

2

1 reference

24 December 2017

Ian Bytheway

series ordinal

3

1 reference

24 December 2017

publication date

1 October 2005

1 reference

24 December 2017

published in

ChemBioChem

1 reference

24 December 2017

volume

6

1 reference

24 December 2017

issue

10

1 reference

24 December 2017

page(s)

1882-1890

1 reference

24 December 2017

https://api.crossref.org/works/10.1002%2FCBIC.200500089

1 reference

Angiogenesis in health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.200500089

Heparin is required for cell-free binding of basic fibroblast growth factor to a soluble receptor and for mitogenesis in whole cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.200500089

Heparin-induced oligomerization of FGF molecules is responsible for FGF receptor dimerization, activation, and cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.200500089

Identification of inhibitors of heparin-growth factor interactions from combinatorial libraries of four-component condensation reactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.200500089

Application of the four-component Ugi condensation for the preparation of sulfated glycoconjugate libraries.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.200500089

Oligosaccharides corresponding to the regular sequence of heparin: chemical synthesis and interaction with FGF-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.200500089

Heparin derivatives as angiogenesis inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.200500089

Structure-activity relationships of heparin-mimicking compounds in induction of bFGF release from extracellular matrix and inhibition of smooth muscle cell proliferation and heparanase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.200500089

High-affinity RNA ligands to basic fibroblast growth factor inhibit receptor binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.200500089

Identification of novel inhibitors of fibroblast growth factor (FGF-2) binding to heparin and endothelial cell survival from a structurally diverse carbohybrid library

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.200500089

Tumor growth dependent on Kaposi's sarcoma-derived fibroblast growth factor inhibited by pentosan polysulfate

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.200500089

Sulfated malto-oligosaccharides bind to basic FGF, inhibit endothelial cell proliferation, and disrupt endothelial cell tube formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.200500089

Short heparin sequences spaced by glycol-split uronate residues are antagonists of fibroblast growth factor 2 and angiogenesis inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.200500089

Treatment with the novel anti-angiogenic agent PI-88 is associated with immune-mediated thrombocytopenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.200500089

Blockade of vascular smooth muscle cell proliferation and intimal thickening after balloon injury by the sulfated oligosaccharide PI-88: phosphomannopentaose sulfate directly binds FGF-2, blocks cellular signaling, and inhibits proliferation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.200500089

Probing the interactions of phosphosulfomannans with angiogenic growth factors by surface plasmon resonance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.200500089

Fibroblast growth factors and their inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.200500089

Solution structure of acidic fibroblast growth factor bound to 1,3, 6-naphthalenetrisulfonate: a minimal model for the anti-tumoral action of suramins and suradistas

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.200500089

Leads for development of new naphthalenesulfonate derivatives with enhanced antiangiogenic activity: crystal structure of acidic fibroblast growth factor in complex with 5-amino-2-naphthalene sulfonate

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.200500089

Use of sulfated linked cyclitols as heparan sulfate mimetics to probe the heparin/heparan sulfate binding specificity of proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.200500089

Molecular modeling as a powerful technique for understanding small-large molecules interactions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.200500089

Inhibition of amine oxidases activity by 1-acetyl-3,5-diphenyl-4,5-dihydro-(1H)-pyrazole derivatives

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.200500089

A structural and dynamic model for the interaction of interleukin-8 and glycosaminoglycans: support from isothermal fluorescence titrations

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.200500089

Validation of molecular docking calculations involving FGF-1 and FGF-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.200500089

Binding constants of neuraminidase inhibitors: An investigation of the linear interaction energy method.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.200500089

Estimation of binding affinities for selective thrombin inhibitors via Monte Carlo simulations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.200500089

Estimation of binding affinities for HEPT and nevirapine analogues with HIV-1 reverse transcriptase via Monte Carlo simulations

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.200500089

Ligand binding affinities from MD simulations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.200500089

Calculation of the Binding Affinity of β-Secretase Inhibitors Using the Linear Interaction Energy Method

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.200500089

Binding affinity prediction with different force fields: examination of the linear interaction energy method

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.200500089

Nature of the interaction of growth factors with suramin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.200500089

Structural studies of the binding of the anti-ulcer drug sucrose octasulfate to acidic fibroblast growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.200500089

Heparin structure and interactions with basic fibroblast growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.200500089

Semianalytical treatment of solvation for molecular mechanics and dynamics

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.200500089

Poly(N-acryl amino acids): A New Class of Biologically Active Polyanions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.200500089

Kinetic and Concentration Analysis Using BIA Technology

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.200500089

21 January 2018

Identifiers

DOI

10.1002/CBIC.200500089

1 reference

24 December 2017

1 reference

24 December 2017